Sort   by:  
 Page size 
MetabolomicsShort-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass

INTRODUCTION: Bariatric surgery is known to be the most effective treatment for weight loss in obese patients and for the rapid remission of obesity-related comorbidities. These short-term improvements result from not only limited digestion or absorption but also dynamic changes ...

2022-03-17 | MTBLS2472 | MetaboLights
TranscriptomicsTranscription profiling of E. coli SL2 cells treated with cycloheximide and LPS
E. coli lipopolysacharide was treated on SL2* cells for 1hr, 4 and 12hrs respectivly. cDNA from those cells was compared with control. For one sample, cyclohexamide was treated for 1hr and then LPS was treated for 4hrs. Then, compared with control.
ORGANISM(S): Drosophila melanogaster 
2004-09-21 | E-MEXP-172 | biostudies-arrayexpress
ProteomicsHuman HeLa cell lince SILAC - The arginylation branch of the N-end rule pathway positively regulates cellular autophagic flux and clearance of proteotoxic proteins
The arginylation branch of the N-end rule pathway positively regulates cellular autophagic flux and clearance of proteotoxic protein
ORGANISM(S): Homo sapiens (Human) 
2016-09-27 | PXD003813 | Pride
Autophage Pca N-end rule 
ProteomicsHuman HeLa cell lince SILAC
The arginylation branch of the N-end rule pathway positively regulates cellular autophagic flux and clearance of proteotoxic protein
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2017-03-29 | MSV000080791 | MassIVE
ProteomicsComprehensive and Unbiased Plasma Proteomics with Proteograph
Mild Cognitive Impairment (MCI) is a precursor to Alzheimer's disease (AD), necessitating early identification through reliable markers. We employed ProteographTM, an automated platform utilizing nanoparticles coupled with a liquid chromatography-tandem mass spectrometry (LC-MS/MS) workflow, enablin...
ORGANISM(S): Homo sapiens (Human) 
2026-09-07 | PXD067951 | Pride
Proteograph Mild cognitive impairment Human plasma 
UnknownConsistent improvement with eculizumab across muscle groups in myasthenia gravis.
Not available
S-EPMC7448154 | biostudies-literature
Sort   by:  
 Page size